Korea's Daewoong Pharma partners with China's Chime Biologics for Dupixent biosimilar development

Chime Biologics, a China-based biologics CDMO dedicated to enabling partners’ success, and South Korea-based Daewo...

June 5, 2026 | Friday | News
Everest Medicines signs $1 B deal with Travere Therapeutics for rare kidney diseases treatment

China-based Everest Medicines has entered into an exclusive licensing and collaboration agreement with US-based Travere ...

June 4, 2026 | Thursday | News
FunPep and Crafton Biotech enter into joint research agreement for therapeutic mRNA vaccines in Japan

Japan-based FunPep and Crafton Biotechnology have entered into a joint research agreement and commenced collaborative re...

June 5, 2026 | Friday | News
M42 and Arcera partner to advance biopharma localisation and next-gen life sciences in Abu Dhabi

M42, a global health leader powered by technology, artificial intelligence, and genomics, and Arcera Life Sciences, a gl...

June 3, 2026 | Wednesday | News
Sciex announces launch of next-generation triple quadrupole mass spectrometer

SCIEX, a Danaher company and leader in life science analytical technologies, has launched the novus V55 system - a next-...

June 3, 2026 | Wednesday | News
China's Haisco Pharma inks $2.9 B deal with Eli Lilly focusing on multiple therapeutic areas

China-based Haisco Pharmaceutical Group has announced a licensing and research collaboration with American firm Eli Lill...

June 3, 2026 | Wednesday | News
Waters announces US FDA 510(k) clearance of BD BACTEC FXI Culture System

Waters Corporation has announced that the BD BACTEC FXI Culture System has received US Food and Drug Administr...

June 4, 2026 | Thursday | News
Korea-based 3billion launches new genomic newborn screening service 3B-NEO

3billion, a South Korea-based AI-powered genomic diagnostics company, has announced the launch of 3B-NEO, a premium...

June 2, 2026 | Tuesday | News
Singapore becomes first APAC market to approve MSD's Enflonsia for infant RSV prevention

MSD, trade name of Merck & Co., Inc., Rahway, N.J., USA, has announced that the Health Sciences Authority (HSA) of S...

June 2, 2026 | Tuesday | News
Japanese dental startup Toregem raises $5.3 M to treat congenital tooth agenesis

Japan-based startup Toregem BioPharma has raised approximately $5.3 million (JPY 850 million) in Pre-Series C financing ...

June 2, 2026 | Tuesday | News
Biond Biologics and Guangzhou-Israel Biotechnology Fund invest $8 M to advance oncology programmes in China

Biond Biologics, a private clinical-stage biotechnology company developing first-in-class immunotherapies for cance...

June 2, 2026 | Tuesday | News
Eli Lilly announces three acquisitions worth $3.7 B to build infectious disease portfolio

US-based Eli Lilly and Company has announced agreements to acquire three companies, Curevo Inc., LimmaTech Biologic...

June 1, 2026 | Monday | News
Innovent Biologics and Pfizer ink $10.5 B deal to develop innovative oncology medicines

China-based Innovent Biologics and American firm Pfizer Inc. have entered into a strategic global licensing and collabor...

June 1, 2026 | Monday | News
Korea's SKIA receives US FDA 510(k) clearance for augmented reality surgical guidance system

South Korea-based medtech innovator SKIA has announced that the US Food and Drug Administration (FDA) has gran...

June 1, 2026 | Monday | News
Meiji Seika Pharma invests in GHIC’s global health security fund

Japan-based Meiji Seika Pharma Co. has committed to invest in the Global Health Security Fund (GHSF), which is sponsored...

June 1, 2026 | Monday | News
“Scalable manufacturing for high-volume siRNA programmes remains underdeveloped”

What were the key takeaways for Hongene after attending TIDES USA 2026? TIDES USA 2026 reinforced several themes that w...

June 2, 2026 | Tuesday | Opinion
SK bioscience secures $230 M from Korea Growth Fund to accelerate Ph 3 development of pneumococcal vaccine

SK bioscience is accelerating late-stage development of its innovative pneumococcal vaccine candidate targeting the glob...

May 29, 2026 | Friday | News
Samsung Epis Holdings establishes new R&D centre in China

Samsung Epis Holdings Co., an investment holding company dedicated to innovation in biopharmaceuticals and biotechnology...

May 29, 2026 | Friday | News
TFBS Bioscience and QIMR Berghofer sign MoU to advance global CGT collaboration

Taiwan-based startup TFBS Bioscience, Inc. and Australia's QIMR Berghofer Medical Research Institute have jointly announ...

May 28, 2026 | Thursday | News
Japan's Asahi Kasei acquires license for novel ADC technology from Noguchi Institute

Japan-based Asahi Kasei Life Science has acquired the license rights for a novel antibody-drug conjugate (ADC) technolog...

May 28, 2026 | Thursday | News
PREMIA and Lind expand AI-powered clinical trial screening across Asia-Pacific

Japanese startup Precision Medicine Asia (PREMIA) and US-based Lind have announced the formation of ...

May 29, 2026 | Friday | News
Japan's Olympus buys BioProtect for $270 M to expand portfolio of urological technologies

Japan-based medtech firm Olympus Corporation has signed a definitive agreement to acquire BioProtect, a medica...

May 27, 2026 | Wednesday | News
Australian medtech startup Oli secures $6.5 M to advance predictive maternal and foetal monitoring

Oli, a wireless, wearable device that monitors maternal and fetal signals, has secured $6.5 million in funding to accele...

May 27, 2026 | Wednesday | News
Mevion Medical Systems marks entry of first-ever proton therapy in Vietnam

US-based Mevion Medical Systems has signed a definitive purchase agreement to bring the MEVION S250-FIT Proton Therapy S...

May 27, 2026 | Wednesday | News
Insilico Medicine and Human Longevity to co-develop industry-first AI foundation model for longevity science

Insilico Medicine, a Hong Kong-headquartered clinical-stage generative artificial intelligence (AI)-driven biotechnology...

May 28, 2026 | Thursday | News